We are live on ! Find out more
LPC

Lion Point Capital Portfolio holdings

AUM $16.7M
1-Year Est. Return 119.35%
This Fund
S&P 500
This Quarter Est. Return
+50.48%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$412M
AUM Growth
+$33.4M
Cap. Flow
-$91M
Cap. Flow %
-22.06%
Top 10 Hldgs %
76.34%
Holding
28
New
3
Increased
2
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$14.5M
2
ARNC
Arconic Corporation
ARNC
+$13.7M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$10.3M
4
LBTYA icon
Liberty Global Class A
LBTYA
+$6.19M
5
SYRE icon
Spyre Therapeutics
SYRE
+$2.29M

Top Sells

Rank Stock Value
1
LSCC icon
Lattice Semiconductor
LSCC
+$35.4M
2
HWM icon
Howmet Aerospace
HWM
+$10.8M
3
CPE
Callon Petroleum Company
CPE
+$4.49M
4
DRRX
DURECT Corp
DRRX
+$1.98M
5
XEC
CIMAREX ENERGY CO
XEC
+$591K

Sector Composition

Rank Sector Weight
1 Technology 34.95%
2 Healthcare 30.59%
3 Energy 7.93%
4 Communication Services 6.76%
5 Materials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSIQ icon
1
Canadian Solar
CSIQ
$950M
$82.6M 20.03%
4,285,066
– –
DRRX
2
DELISTED
DURECT Corp
DRRX
$43.1M 10.46%
1,859,330
-89,916
-5% -$1.98M
ACHC icon
3
Acadia Healthcare
ACHC
$3.23B
$39.1M 9.49%
1,558,472
– –
MRNS
4
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$27.6M 6.7%
2,718,335
+1,124,650
+71% +$10.3M
LBTYA icon
5
Liberty Global Class A
LBTYA
$3.26B
$27.3M 6.63%
1,250,000
+300,000
+32% +$6.19M
PRSP
6
DELISTED
Perspecta Inc. Common Stock
PRSP
$20.9M 5.07%
900,000
– –
SWIR
7
DELISTED
Sierra Wireless
SWIR
$19.3M 4.67%
2,144,396
– –
AA icon
8
Alcoa
AA
$11.9B
$19.1M 4.63%
1,698,382
– –
PDCE
9
DELISTED
PDC Energy, Inc.
PDCE
$18.2M 4.42%
1,466,079
– –
TGTX icon
10
TG Therapeutics
TGTX
$8.4B
$17.5M 4.24%
+897,799
New +$14.5M
ARNC
11
DELISTED
Arconic Corporation
ARNC
$16.3M 3.95%
+1,168,749
New +$13.7M
BATL icon
12
Battalion Oil
BATL
$35M
$13.6M 3.29%
1,429,976
– –
KNSA icon
13
Kiniksa Pharmaceuticals
KNSA
$4.85B
$12.6M 3.06%
495,748
– –
XOP icon
14
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
$12.4M 3.01%
237,500
-78,750
-25% -$3.98M
LSCC icon
15
Lattice Semiconductor
LSCC
$18.4B
$11.9M 2.88%
418,188
-1,515,000
-78% -$35.4M
LUMO
16
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$6.71M 1.63%
407,192
– –
SCOR icon
17
Comscore
SCOR
$110M
$5.96M 1.45%
96,112
– –
OUT icon
18
Outfront Media
OUT
$5.65B
$4.25M 1.03%
304,793
– –
LOGC
19
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$4.23M 1.03%
500,000
– –
EXTR icon
20
Extreme Networks
EXTR
$3.89B
$3.52M 0.85%
811,835
– –
SYRE icon
21
Spyre Therapeutics
SYRE
$8.9B
$2.77M 0.67%
+12,000
New +$2.29M
OPESU
22
DELISTED
Opes Acquisition Corp. Unit
OPESU
$1.94M 0.47%
83,438
– –
OVV icon
23
Ovintiv
OVV
$17.7B
$860K 0.21%
90,108
– –
LBTYK icon
24
Liberty Global Class C
LBTYK
$3.19B
$537K 0.13%
25,000
– –
HWM icon
25
Howmet Aerospace
HWM
$116B
– –
-880,200
Closed -$10.8M
1
2

Similar funds

PA
PPM America Chicago, Illinois $16.6M AUM 31.99% 1-Year Est. Return
PA
Prossimo Advisors San Luis Obispo, California $16.4M AUM 14% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
CP
Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return
B
BP London, United Kingdom $17.7M AUM 12.34% 1-Year Est. Return
CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Lion Point Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Lion Point Capital held 28 positions worth $412M, up 8.8% from $379M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Lion Point Capital withdrew a net $91M in Q2 2020, closing 4 positions and reducing 3 holdings. Its most notable exit was Howmet Aerospace, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Lion Point Capital opened a new position in TG Therapeutics worth $17.5M.

  • Lion Point Capital's largest Q2 2020 buy was TG Therapeutics: 897,799 shares worth $17.5M.
  • Lion Point Capital added most to Marinus Pharmaceuticals, Inc in Q2 2020, an estimated $10.3M increase.
  • Lion Point Capital's biggest Q2 2020 reduction was Lattice Semiconductor, cutting an estimated $35.4M.
  • Lion Point Capital fully exited Howmet Aerospace in Q2 2020, selling an estimated $10.8M.
  • Lion Point Capital's ten largest holdings make up 76% of its $412M portfolio in Q2 2020.
  • Lion Point Capital opened 3 new positions and closed 4 in Q2 2020.
  • Lion Point Capital's portfolio value rose 8.8% quarter-over-quarter to $412M.

Based on Lion Point Capital's 13F filing for Q2 2020, filed 14 Aug 2020.